In addition, activation of FGF21 pathway may correlate with the effect of SGLT2 inhibitors on protecting the renal function in type 2 diabetes and delaying progression of CKD (Packer, 2020). The gene discussed is FGF21; the disease is type 2 diabetes mellitus.